Related Experiment Video

Updated: Apr 6, 2026

Optocardiography and Electrophysiology Studies of Ex Vivo Langendorff-perfused Hearts
09:52

Optocardiography and Electrophysiology Studies of Ex Vivo Langendorff-perfused Hearts

Published on: November 7, 2019

13.9K

The pediatric heart network: meeting the challenges to multicenter studies in pediatric heart disease

Kristin M Burns1, Victoria L Pemberton, Gail D Pearson

  • 1National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.

Current Opinion in Pediatrics
|July 22, 2015
PubMed

Insights

Conducting multicenter studies for pediatric heart disease is crucial for validating new therapies. Lessons from the Pediatric Heart Network (PHN) offer guidance for future collaborative research in pediatric cardiovascular disease.

Area of Science:

  • Pediatric Cardiology
  • Clinical Research
  • Multicenter Studies

Background:

  • Pediatric congenital heart disease (CHD) patient numbers are small per center, necessitating multicenter studies.
  • Validating new medical or surgical therapies for CHD requires robust clinical evidence.
  • The Pediatric Heart Network (PHN) has 15 years of experience in multicenter research for pediatric cardiovascular disease.

Purpose of the Study:

  • To describe challenges in conducting high-quality multicenter research in pediatric cardiovascular disease.
  • To outline strategies employed by the PHN to overcome these challenges.
  • To provide guidance for investigators undertaking pediatric multicenter studies.

Main Methods:

  • Review of experiences from the Pediatric Heart Network (PHN).
  • Analysis of challenges encountered in collaborative pediatric cardiovascular research.
  • Identification of successful strategies for multicenter study implementation.

Main Results:

  • Multicenter studies face unique logistical and collaborative hurdles.
  • The PHN has developed effective strategies to ensure high-quality research.
  • Sharing these experiences can improve future multicenter research endeavors.

Conclusions:

  • Lessons learned from the PHN are valuable for researchers in pediatric cardiovascular disease.
  • Successful multicenter studies require careful planning and execution.
  • Guidance from experienced networks can facilitate the advancement of pediatric heart disease therapies.
Abstract

More Related Videos

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension09:23

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Published on: February 11, 2017

17.7K
Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption12:43

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption

Published on: August 16, 2016

21.2K

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
456
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
484
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
581
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
675
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
341